SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-24-039126
Filing Date
2024-05-02
Accepted
2024-05-02 16:16:05
Documents
5

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0205012-s3_protara.htm S-3 354018
2 OPINION OF SULLIVAN & CROMWELL LLP ea020501201ex5-1_protara.htm EX-5.1 10567
3 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea020501201ex23-1_protara.htm EX-23.1 4297
4 CALCULATION OF FILING FEE TABLE ea020501201ex-fee_protara.htm EX-FILING FEES 43399
5 GRAPHIC image_001.jpg GRAPHIC 5675
  Complete submission text file 0001213900-24-039126.txt   421464
Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-279067 | Film No.: 24908512
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)